NZ335892A - Cephalosporin derivatives for treating bacterial infections - Google Patents

Cephalosporin derivatives for treating bacterial infections

Info

Publication number
NZ335892A
NZ335892A NZ335892A NZ33589297A NZ335892A NZ 335892 A NZ335892 A NZ 335892A NZ 335892 A NZ335892 A NZ 335892A NZ 33589297 A NZ33589297 A NZ 33589297A NZ 335892 A NZ335892 A NZ 335892A
Authority
NZ
New Zealand
Prior art keywords
compound
group
hydrogen
co2h
substituted
Prior art date
Application number
NZ335892A
Other languages
English (en)
Inventor
Dane M Springer
Bing Y Luh
Andrea Stanley V D
Thomas W Hudyma
Oak K Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NZ335892A publication Critical patent/NZ335892A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ335892A 1996-11-27 1997-11-21 Cephalosporin derivatives for treating bacterial infections NZ335892A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
PCT/US1997/021785 WO1998023621A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Publications (1)

Publication Number Publication Date
NZ335892A true NZ335892A (en) 2001-07-27

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335892A NZ335892A (en) 1996-11-27 1997-11-21 Cephalosporin derivatives for treating bacterial infections

Country Status (17)

Country Link
EP (1) EP0966472A1 (US20020095090A1-20020718-M00002.png)
JP (1) JP2001506607A (US20020095090A1-20020718-M00002.png)
KR (1) KR20000057283A (US20020095090A1-20020718-M00002.png)
CN (1) CN1238775A (US20020095090A1-20020718-M00002.png)
AR (1) AR010650A1 (US20020095090A1-20020718-M00002.png)
AU (1) AU734948B2 (US20020095090A1-20020718-M00002.png)
BR (1) BR9713350A (US20020095090A1-20020718-M00002.png)
CA (1) CA2272717A1 (US20020095090A1-20020718-M00002.png)
CZ (1) CZ185399A3 (US20020095090A1-20020718-M00002.png)
HU (1) HUP9903621A3 (US20020095090A1-20020718-M00002.png)
IL (1) IL129437A0 (US20020095090A1-20020718-M00002.png)
NO (1) NO992526L (US20020095090A1-20020718-M00002.png)
NZ (1) NZ335892A (US20020095090A1-20020718-M00002.png)
PL (1) PL334558A1 (US20020095090A1-20020718-M00002.png)
TW (1) TW414796B (US20020095090A1-20020718-M00002.png)
WO (1) WO1998023621A1 (US20020095090A1-20020718-M00002.png)
ZA (1) ZA9710662B (US20020095090A1-20020718-M00002.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
KR20140034798A (ko) * 2011-05-18 2014-03-20 신젠타 파티서페이션즈 아게 아릴티오아세트아미드 유도체에 기반한 살곤충 화합물
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
AU1278197A (en) * 1995-12-20 1997-07-14 Bristol-Myers Squibb Company Cephalosporin derivatives

Also Published As

Publication number Publication date
JP2001506607A (ja) 2001-05-22
IL129437A0 (en) 2000-02-17
PL334558A1 (en) 2000-03-13
CA2272717A1 (en) 1998-06-04
CN1238775A (zh) 1999-12-15
EP0966472A4 (US20020095090A1-20020718-M00002.png) 1999-12-29
AR010650A1 (es) 2000-06-28
BR9713350A (pt) 2000-01-25
AU5365298A (en) 1998-06-22
AU734948B2 (en) 2001-06-28
NO992526D0 (no) 1999-05-26
HUP9903621A3 (en) 2001-05-28
WO1998023621A1 (en) 1998-06-04
KR20000057283A (ko) 2000-09-15
NO992526L (no) 1999-05-26
CZ185399A3 (cs) 1999-08-11
TW414796B (en) 2000-12-11
HUP9903621A2 (hu) 2000-04-28
EP0966472A1 (en) 1999-12-29
ZA9710662B (en) 1999-05-26

Similar Documents

Publication Publication Date Title
US6265394B1 (en) Bis quaternary MRSA cephem derivatives
US5859256A (en) Cephalosporin antibiotics
AU734948B2 (en) Cephalosporin derivatives
AU702187B2 (en) Cephalosporin derivatives
US5559108A (en) Cephalosporin derivatives
US5620969A (en) Cephalosporin derviatives
US6025352A (en) Cephalosporin antibiotics
US6093712A (en) Cephalosporin derivatives
US5734047A (en) Cephalosporin derivatives
KR910006807B1 (ko) 카바펜엠 항생제의 제조방법
US20020049191A1 (en) Cephalosporin derivatives
WO1997037997A1 (en) Cephalosporin derivatives
MXPA99004823A (en) Cephalosporin derivatives
US6030965A (en) Cephalosporin antibiotics
RU2172317C2 (ru) Производные цефалоспорина, содержащая их антибактериальная композиция, производные 2-аминотиазолов в качестве промежуточных соединений и способ их получения
WO1999006048A1 (en) Bis quaternary mrsa cephem derivatives
EP1059293A1 (en) Novel amino chlorothiazole compounds
NZ500512A (en) Cephalosporin for treating beta-lactam antibiotic resistant bacteria (such as S. aureus, E. faecium or E. faecalis) or PBP2a-producing bacteria

Legal Events

Date Code Title Description
PSEA Patent sealed